Cargando…

Editorial: Gut Microbiota and Inflammation: Relevance in Cancer and Cardiovascular Disease

Detalles Bibliográficos
Autores principales:	Parolini, Cinzia, Amedei, Amedeo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786398/ https://www.ncbi.nlm.nih.gov/pubmed/33424614 http://dx.doi.org/10.3389/fphar.2020.613511

Ejemplares similares

Cardiovascular Diseases and Pharmacomicrobiomics: A Perspective on Possible Treatment Relevance
por: Curini, Lavinia, et al.
Publicado: (2021)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases
por: Wang, Xiaoping, et al.
Publicado: (2022)

Editorial: Dietary polyphenols, gut microbiota, and human health
por: Xu, Lei, et al.
Publicado: (2023)

Editorial: Inflammation in Cardiovascular Diseases: Role of the Endothelium and Emerging Therapeutics
por: Qin, Cheng Xue, et al.
Publicado: (2020)

Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target
por: Yang, Shengjie, et al.
Publicado: (2019)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
por: Yan, Aiwei, et al.
Publicado: (2023)

Circulating Metabolites Originating from Gut Microbiota Control Endothelial Cell Function
por: Amedei, Amedeo, et al.
Publicado: (2019)

Editorial: Advances in inflammatory bowel disease: Mucosal defense mechanisms against gut inflammation
por: Corr, Sinéad C., et al.
Publicado: (2023)

Role of diet and gut microbiota on colorectal cancer immunomodulation
por: De Almeida, Carolina Vieira, et al.
Publicado: (2019)

I’ve Gut A Feeling: Microbiota Impacting the Conceptual and Experimental Perspectives of Personalized Medicine
por: Amedei, Amedeo, et al.
Publicado: (2018)

Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids
por: Li, Qinyu, et al.
Publicado: (2021)

Editorial of Special Issue “Pharmacomicrobiomics in Non-Communicable Disease”
por: Amedei, Amedeo
Publicado: (2022)

Role of Butyrate, a Gut Microbiota Derived Metabolite, in Cardiovascular Diseases: A comprehensive narrative review
por: Amiri, Parichehr, et al.
Publicado: (2022)

Canagliflozin Prevents Lipid Accumulation, Mitochondrial Dysfunction, and Gut Microbiota Dysbiosis in Mice With Diabetic Cardiovascular Disease
por: Wang, Xueliang, et al.
Publicado: (2022)

Resveratrol Modulates the Gut Microbiota and Inflammation to Protect Against Diabetic Nephropathy in Mice
por: Cai, Ting-Ting, et al.
Publicado: (2020)

Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis
por: Liang, Wenyi, et al.
Publicado: (2021)

Editorial: Autophagy in Inflammation Related Diseases
por: Shao, Bo-Zong, et al.
Publicado: (2022)

Editorial: Emerging mechanisms in cardiovascular disease
por: Yalcin, Huseyin C., et al.
Publicado: (2023)

Microbiota and Colorectal Cancer: From Gut to Bedside
por: Silva, Miguel, et al.
Publicado: (2021)

Phillygenin Attenuates Carbon Tetrachloride-Induced Liver Fibrosis via Modulating Inflammation and Gut Microbiota
por: Wang, Cheng, et al.
Publicado: (2021)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease
por: Petrillo, Francesco, et al.
Publicado: (2021)

Editorial: Adipose Tissue in the Cardiovascular Homeostasis and Disease
por: Butcher, Joshua T., et al.
Publicado: (2021)

Editorial: Circadian biology, cardiovascular function and disease
por: Chong, Nelson, et al.
Publicado: (2023)

Editorial of Special Issue “The Interplay of Microbiome and Immune Response in Health and Diseases—2nd Edition”
por: Amedei, Amedeo
Publicado: (2022)

Calcific Aortic Valve Disease-Natural History and Future Therapeutic Strategies
por: Alushi, Brunilda, et al.
Publicado: (2020)

The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease
por: Zhang, Qing, et al.
Publicado: (2021)

Gut microbiota in alcohol-related liver disease: pathophysiology and gut-brain cross talk
por: Zhu, Lin, et al.
Publicado: (2023)

Editorial: Impact of the gut microbiota on cardiovascular medicine
por: Haghikia, Arash, et al.
Publicado: (2022)

Editorial: Fungal Bioactive Metabolites of Pharmacological Relevance
por: Fasinu, Pius S., et al.
Publicado: (2022)

NSAID–Gut Microbiota Interactions
por: Maseda, Damian, et al.
Publicado: (2020)

Editorial: Cardiovascular remodeling
por: Yang, Yan, et al.
Publicado: (2023)

Polydextrose Alleviates Adipose Tissue Inflammation and Modulates the Gut Microbiota in High-Fat Diet-Fed Mice
por: Hu, Qiuyue, et al.
Publicado: (2022)

Naoxintong Capsule Inhibits the Development of Cardiovascular Pathological Changes in Bama Minipig Through Improving Gut Microbiota
por: Zhang, Wei-jian, et al.
Publicado: (2019)

Editorial: Autophagy and Related Transcription Factors in Liver and Gut Diseases
por: Eid, Nabil, et al.
Publicado: (2020)

Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease
por: Zhang, Bo, et al.
Publicado: (2022)

The interplay between herbal medicines and gut microbiota in metabolic diseases
por: Wang, Lijie, et al.
Publicado: (2023)

Editorial: Enteric inflammation and chronic diseases: Is there a link?
por: Marzocco, Stefania, et al.
Publicado: (2022)

Editorial: Autophagy in inflammation related diseases, volume II
por: Shao, Bo-Zong, et al.
Publicado: (2023)

The role of gut microbiota and drug interactions in the development of colorectal cancer
por: Wu, Jinna, et al.
Publicado: (2023)

Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model
por: Li, Hu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l2cslo38avq4i8o5ovs1kkaus7